BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10083264)

  • 1. Role of Fas in recurrence of autoimmune diabetes after islet transplantation.
    Guo Z; Shen J; Mital D; Hong Y; Jensik SC; Williams JW
    Transplant Proc; 1999; 31(1-2):622. PubMed ID: 10083264
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice.
    Guo Z; Chong AS; Tian Y; Shen J; Yin D; Mital D; Foster P; Sankary H; McChesney L; Jensik S; Williams JW
    Transplant Proc; 1997 Jun; 29(4):2155. PubMed ID: 9193568
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
    Rastellini C; Cicalese L; Leach R; Braun M; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):646-7. PubMed ID: 10083278
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes.
    Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
    Transplant Proc; 1998 Mar; 30(2):463-4. PubMed ID: 9532129
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of concordant islet xenografts with leflunomide.
    Lakey JR; Yatscoff RW; Koshal A; Rajotte RV
    Transplant Proc; 1996 Apr; 28(2):816. PubMed ID: 8623414
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine.
    Mital D; Guo Z; Chong AS; Fu Z; Tian Y; Foster PF; Jensik S; Shen J; Sankary HN; McChesney LP; Williams JW
    Transplant Proc; 1997 Jun; 29(4):2166-7. PubMed ID: 9193573
    [No Abstract]   [Full Text] [Related]  

  • 7. Islet xenografting in autoimmune diabetes.
    Gill RG; Coulombe M
    Transplant Proc; 1994 Jun; 26(3):1140. PubMed ID: 7913256
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.
    Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
    Transplantation; 1998 May; 65(10):1310-4. PubMed ID: 9625011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant role for Fas in the pathogenesis of autoimmune diabetes.
    Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y
    J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of xenograft resistance to autoimmune disease recurrence after pancreas islet transplantation.
    Thomas F; Pittman K; Larkin E; Berzina P; Contreras J; Quarantillo P; Thomas J
    Transplant Proc; 1999; 31(1-2):964-5. PubMed ID: 10083429
    [No Abstract]   [Full Text] [Related]  

  • 12. Leflunomide, a potential immunosuppressant for pancreatic islet transplantation.
    Guo Z; Chong AS; Shen J; Foster P; Sankary HN; McChesney L; Mital D; Jensik SC; Gebel H; Williams JW
    Transplant Proc; 1997; 29(1-2):1296-7. PubMed ID: 9123314
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice.
    Gysemans C; Waer M; Laureys J; Bouillon R; Mathieu C
    Transplant Proc; 2001 May; 33(3):2094-5. PubMed ID: 11377464
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended functional survival of murine islet allografts with 15-deoxyspergualin.
    Kaufman DB; Field MJ; Gruber SA; Farney AC; Stephanian E; Gores PF; Sutherland DE
    Transplant Proc; 1992 Jun; 24(3):1045-7. PubMed ID: 1604510
    [No Abstract]   [Full Text] [Related]  

  • 16. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
    Duvivier-Kali VF; Omer A; Parent RJ; O'Neil JJ; Weir GC
    Diabetes; 2001 Aug; 50(8):1698-705. PubMed ID: 11473027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide and cyclosporin-A prolong fish-to-mouse islet xenograft survival in BALB/C mice.
    Wright JR; Kearns H; McDonald AS
    Transplant Proc; 1994 Jun; 26(3):1310. PubMed ID: 8029918
    [No Abstract]   [Full Text] [Related]  

  • 18. Islet rejection in perforin-deficient mice: the role of perforin and Fas.
    Ahmed KR; Guo TB; Gaal KK
    Transplantation; 1997 Apr; 63(7):951-7. PubMed ID: 9112346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
    Wennberg L; Song Z; Bennet W; Zhang J; Nava S; Sundberg B; Bari S; Groth CG; Korsgren O
    Transplantation; 2001 Apr; 71(8):1024-33. PubMed ID: 11374396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice.
    Iwata H; Takagi T; Yamashita K; Kobayashi K; Amemiya H
    Transplant Proc; 1992 Jun; 24(3):997. PubMed ID: 1604705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.